JAGUAR HEALTH, INC. Gain (Loss) on Extinguishment of Debt
JAGUAR HEALTH, INC. (JAGX) reported Gain (Loss) on Extinguishment of Debt of -$3.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-19
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$3.50M.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was -$628.00K.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $23.00K.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$1.80M, a 244.50% decline from fiscal 2024.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $1.25M, a 66.32% decline from fiscal 2023.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $3.70M.
- JAGUAR HEALTH, INC. gain (loss) on extinguishment of debt for fiscal 2022 was -$2.19M.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 1 month as first filed | Gain (Loss) on Extinguishment of Debt 2 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.50M 10-Q · filed 2026-08-19 | -$4.13M 10-Q · filed 2026-08-19 | -$4.11M derived: sum of 3 quarters · filed 2026-08-19 | -$4.11M derived: sum of 4 quarters · filed 2026-08-19 | ||||||||
| 2026-03-31 | -$628.00K 10-Q · filed 2026-05-20 | -$605.00K derived: sum of 2 quarters · filed 2026-05-20 | -$605.00K derived: sum of 3 quarters · filed 2026-05-20 | -$2.43M derived: sum of 4 quarters · filed 2026-08-19 | ||||||||
| 2025-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $23.00K derived: sum of 2 quarters · filed 2026-04-07 | -$1.80M derived: sum of 3 quarters · filed 2026-08-19 | -$1.80M 10-K · filed 2026-04-07 | ||||||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.82M derived: sum of 2 quarters · filed 2026-08-19 | -$1.82M 10-Q · filed 2025-11-14 | -$1.82M derived: sum of 4 quarters · filed 2026-08-19 | ||||||||
| 2025-06-30 | -$1.82M 10-Q · filed 2026-08-19 | -$1.82M 10-Q · filed 2026-08-19 | -$1.82M derived: sum of 3 quarters · filed 2026-08-19 | -$1.82M derived: sum of 4 quarters · filed 2026-08-19 | ||||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-20 | $0.00 derived: sum of 2 quarters · filed 2026-05-20 | $0.00 derived: sum of 3 quarters · filed 2026-05-20 | $0.00 derived: sum of 4 quarters · filed 2026-05-20 | ||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $0.00 derived: sum of 3 quarters · filed 2026-04-07 | $1.25M 10-K · filed 2026-04-07 | ||||||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $1.25M 10-Q · filed 2025-11-14 | $1.25M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.25M 10-Q · filed 2025-08-14 | $1.25M derived: sum of 3 quarters · filed 2025-08-14 | $4.94M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-15 | $1.25M derived: sum of 2 quarters · filed 2025-05-15 | $4.94M derived: sum of 3 quarters · filed 2025-05-15 | $4.94M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.70M derived: sum of 2 quarters · filed 2025-03-31 | $3.70M derived: sum of 3 quarters · filed 2025-03-31 | $3.70M 10-K · filed 2025-03-31 | ||||||||
| 2023-09-30 | $3.70M 10-Q · filed 2024-11-13 | $3.70M derived: sum of 2 quarters · filed 2024-11-13 | $3.70M 10-Q · filed 2024-11-13 | $3.70M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $0.00 derived: sum of 4 quarters · filed 2024-04-01 | ||||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $628.00K derived: sum of 4 quarters · filed 2024-04-01 | ||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $628.00K derived: sum of 3 quarters · filed 2024-04-01 | -$2.19M 10-K · filed 2024-04-01 | ||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $628.00K derived: sum of 2 quarters · filed 2023-11-14 | -$2.19M 10-Q · filed 2023-11-14 | -$2.19M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||
| 2022-06-30 | $628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.19M 10-Q · filed 2023-08-14 | -$2.19M derived: sum of 3 quarters · filed 2023-08-14 | -$2.19M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||
| 2022-03-31 | -$2.81M 10-Q · filed 2023-05-15 | -$2.81M derived: sum of 2 quarters · filed 2023-05-15 | -$2.81M derived: sum of 3 quarters · filed 2023-05-15 | -$2.81M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | $0.00 derived: sum of 3 quarters · filed 2023-03-24 | -$753.00K 10-K · filed 2023-03-24 | ||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$753.00K 10-Q · filed 2022-11-14 | |||||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$753.00K 10-Q · filed 2022-08-22 | ||||||||||
| 2021-03-31 | -$753.00K 10-Q · filed 2022-05-10 | |||||||||||
| 2021-01-31 | -$753.00K 10-K · filed 2023-03-24 | $753.00K 10-Q · filed 2021-05-17 | ||||||||||
| 2020-12-31 | -$1.86M 10-K · filed 2022-03-11 | |||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$336.00K derived: sum of 2 quarters · filed 2021-03-31 | -$3.00M derived: sum of 3 quarters · filed 2021-03-31 | -$4.94M 10-K · filed 2021-03-31 | -$4.94M 10-K · filed 2020-04-03 | |||||||
| 2019-09-30 | -$336.00K 10-Q · filed 2020-11-16 | -$335.75K 10-Q · filed 2019-11-14 | -$3.00M derived: sum of 2 quarters · filed 2020-11-16 | -$4.94M 10-Q · filed 2020-11-16 | -$4.94M 10-Q · filed 2019-11-14 | |||||||
| 2019-06-30 | $428.78K 10-K · filed 2020-04-03 | -$2.66M 10-Q · filed 2020-08-13 | -$2.66M 10-Q · filed 2019-08-14 | -$4.61M 10-Q · filed 2020-08-13 | -$4.61M 10-Q · filed 2019-08-14 | |||||||
| 2019-03-31 | -$1.94M 10-Q · filed 2020-05-15 | -$1.94M 10-Q · filed 2019-05-21 | ||||||||||
| 2018-12-31 | -$544.44K 10-K · filed 2020-04-03 | |||||||||||
| 2017-12-31 | -$269.34K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | -$269.34K derived: sum of 2 quarters · filed 2019-04-10 | -$269.34K derived: sum of 3 quarters · filed 2019-04-10 | -$477.05K 10-K · filed 2019-04-10 | ||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $0.00 derived: sum of 2 quarters · filed 2018-11-19 | -$207.71K 10-Q · filed 2018-11-19 | |||||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$207.71K 10-Q · filed 2018-08-13 | ||||||||||
| 2017-03-31 | -$207.71K 10-Q · filed 2018-05-15 | |||||||||||
| 2016-12-31 | -$108.00K 10-K · filed 2018-04-09 | |||||||||||
| 2016-11-08 | -$108.00K 10-K · filed 2018-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |